Inge Bruggeman

1.6k total citations · 1 hit paper
10 papers, 1.3k citations indexed

About

Inge Bruggeman is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Inge Bruggeman has authored 10 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Inge Bruggeman's work include Cell death mechanisms and regulation (5 papers), interferon and immune responses (3 papers) and CRISPR and Genetic Engineering (2 papers). Inge Bruggeman is often cited by papers focused on Cell death mechanisms and regulation (5 papers), interferon and immune responses (3 papers) and CRISPR and Genetic Engineering (2 papers). Inge Bruggeman collaborates with scholars based in Belgium, United States and France. Inge Bruggeman's co-authors include Peter Vandenabeele, Ria Roelandt, Mathieu J.M. Bertrand, Yves Dondelinger, Kathrin Weber, Amanda Gonçalves, Paco Hulpiau, Wim Declercq, Savvas N. Savvides and John Bertin and has published in prestigious journals such as Nature Communications, Immunity and Nature Cell Biology.

In The Last Decade

Inge Bruggeman

10 papers receiving 1.3k citations

Hit Papers

MLKL Compromises Plasma Membrane Integrity by Binding to ... 2014 2026 2018 2022 2014 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Bruggeman Belgium 7 1.1k 531 187 149 139 10 1.3k
Matija Zelic United States 11 1.0k 1.0× 788 1.5× 156 0.8× 193 1.3× 133 1.0× 13 1.4k
Mike Hupe Germany 10 1.0k 1.0× 562 1.1× 171 0.9× 247 1.7× 171 1.2× 10 1.3k
Katherine Oravecz-Wilson United States 23 696 0.7× 418 0.8× 118 0.6× 167 1.1× 273 2.0× 50 1.3k
Beate Kellert Germany 7 886 0.8× 535 1.0× 152 0.8× 198 1.3× 147 1.1× 7 1.1k
Il‐Young Hwang United States 20 572 0.5× 539 1.0× 137 0.7× 57 0.4× 144 1.0× 40 1.2k
Vanessa S. Marsden Australia 11 1.0k 1.0× 528 1.0× 221 1.2× 156 1.0× 246 1.8× 11 1.4k
Yinming Liang China 20 584 0.6× 621 1.2× 129 0.7× 209 1.4× 219 1.6× 76 1.4k
Ahmad M. Kamal United Kingdom 12 813 0.8× 501 0.9× 339 1.8× 162 1.1× 91 0.7× 20 1.2k
Alison J. Darmon Canada 11 792 0.8× 420 0.8× 173 0.9× 94 0.6× 223 1.6× 15 1.2k
Shani Ben‐Moshe Israel 11 623 0.6× 212 0.4× 265 1.4× 118 0.8× 196 1.4× 15 1.2k

Countries citing papers authored by Inge Bruggeman

Since Specialization
Citations

This map shows the geographic impact of Inge Bruggeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Bruggeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Bruggeman more than expected).

Fields of papers citing papers by Inge Bruggeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Bruggeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Bruggeman. The network helps show where Inge Bruggeman may publish in the future.

Co-authorship network of co-authors of Inge Bruggeman

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Bruggeman. A scholar is included among the top collaborators of Inge Bruggeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Bruggeman. Inge Bruggeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Delanghe, Tom, et al.. (2025). TAB2 controls a TAK1-independent cell death checkpoint at the level of TNFR1 complex II in the TNF pathway. Cell Death and Differentiation. 33(1). 64–76. 2 indexed citations
2.
Coster, Wouter De, Ida Höijer, Inge Bruggeman, et al.. (2024). Visualization and analysis of medically relevant tandem repeats in nanopore sequencing of control cohorts with pathSTR. Genome Research. 34(11). 2074–2080. 5 indexed citations
3.
Bruggeman, Inge, Bahar Golabi, Elfride De Baere, et al.. (2024). Evolutionary origin of Hoxc13-dependent skin appendages in amphibians. Nature Communications. 15(1). 2328–2328. 6 indexed citations
4.
Weber, Kathrin, Ria Roelandt, Inge Bruggeman, Yann Estornes, & Peter Vandenabeele. (2018). Nuclear RIPK3 and MLKL contribute to cytosolic necrosome formation and necroptosis. Communications Biology. 1(1). 6–6. 129 indexed citations
5.
Estornes, Yann, Yves Dondelinger, Kathrin Weber, et al.. (2018). N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis. Cell Death and Disease. 9(5). 494–494. 15 indexed citations
6.
Dondelinger, Yves, Tom Delanghe, Diego Rojas‐Rivera, et al.. (2017). MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death. Nature Cell Biology. 19(10). 1237–1247. 162 indexed citations
7.
Groote, Philippe De, Sasker Grootjans, Saskia Lippens, et al.. (2016). Generation of a New Gateway-Compatible Inducible Lentiviral Vector Platform Allowing Easy Derivation of Co-Transduced Cells. BioTechniques. 60(5). 252–259. 10 indexed citations
8.
Berghe, Tom Vanden, Paco Hulpiau, Liesbet Martens, et al.. (2015). Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice. Immunity. 43(1). 200–209. 125 indexed citations
9.
Dondelinger, Yves, Wim Declercq, Sylvie Montessuit, et al.. (2014). MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates. Cell Reports. 7(4). 971–981. 663 indexed citations breakdown →
10.
Remijsen, Quinten, Vera Goossens, Sasker Grootjans, et al.. (2014). Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis. Cell Death and Disease. 5(1). e1004–e1004. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026